181 related articles for article (PubMed ID: 37269812)
1. Role of m6A modification in immune microenvironment of digestive system tumors.
Li C; Zhu M; Wang J; Wu H; Liu Y; Huang D
Biomed Pharmacother; 2023 Aug; 164():114953. PubMed ID: 37269812
[TBL] [Abstract][Full Text] [Related]
2. Emerging function of main RNA methylation modifications in the immune microenvironment of digestive system tumors.
Zeng Y; Yu T; Lou Z; Chen L; Pan L; Ruan B
Pathol Res Pract; 2024 Apr; 256():155268. PubMed ID: 38547773
[TBL] [Abstract][Full Text] [Related]
3. Systematic analysis of molecular characterization and clinical relevance of m6A regulators in digestive system pan-cancers.
Kou T; Chai R; Jin L; Bai Z; Yang Y; Zhao Y; Wu D; Zhang Z; Yang Y
Exp Biol Med (Maywood); 2021 Sep; 246(18):2007-2018. PubMed ID: 34102905
[TBL] [Abstract][Full Text] [Related]
4. N6-methyladenosine modification and metabolic reprogramming of digestive system malignancies.
Cai X; Liang C; Zhang M; Xu Y; Weng Y; Li X; Yu W
Cancer Lett; 2022 Sep; 544():215815. PubMed ID: 35798087
[TBL] [Abstract][Full Text] [Related]
5. Characterization of m6A methylation modifications and tumor microenvironment infiltration in thyroid cancer.
Ji FH; Yang Z; Sun C; Lowe S; Qiu XG
Clin Transl Oncol; 2023 Jan; 25(1):269-282. PubMed ID: 36163443
[TBL] [Abstract][Full Text] [Related]
6. The potential role of m6A modifications on immune cells and immunotherapy.
Gan L; Zhao Y; Fu Y; Chen Q
Biomed Pharmacother; 2023 Apr; 160():114343. PubMed ID: 36758318
[TBL] [Abstract][Full Text] [Related]
7. Characteristic of molecular subtypes in lung adenocarcinoma based on m6A RNA methylation modification and immune microenvironment.
Zhou H; Zheng M; Shi M; Wang J; Huang Z; Zhang H; Zhou Y; Shi J
BMC Cancer; 2021 Aug; 21(1):938. PubMed ID: 34416861
[TBL] [Abstract][Full Text] [Related]
8. The significance of m6A RNA methylation modification in prognosis and tumor microenvironment immune infiltration of cervical cancer.
Guo Y; Bai Y; Wang L; Xu Z; Wang X; Wang W
Medicine (Baltimore); 2022 Jul; 101(26):e29818. PubMed ID: 35777046
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of m6A RNA Methylation Regulators and the Tumor Immune Microenvironment in Non-Small-Cell Lung Cancer.
Zhu J; Jiang Y; Wang T; Wu A; Zhou T; Zhang A; Tang Y; Shen Z; Wang J; Zhou H; Shi J; Chen J
Dis Markers; 2022; 2022():2989200. PubMed ID: 35186164
[TBL] [Abstract][Full Text] [Related]
10. N6-Methyladenosine Regulator-Mediated Immue Patterns and Tumor Microenvironment Infiltration Characterization in Glioblastoma.
Xiong W; Li C; Wan B; Zheng Z; Zhang Y; Wang S; Fan J
Front Immunol; 2022; 13():819080. PubMed ID: 35359993
[TBL] [Abstract][Full Text] [Related]
11. Correlation analysis of m6A-modified regulators with immune microenvironment infiltrating cells in lung adenocarcinoma.
Ye W; Huang T
PLoS One; 2022; 17(2):e0264384. PubMed ID: 35196365
[TBL] [Abstract][Full Text] [Related]
12. The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma.
Chen F; Xie X; Chao M; Cao H; Wang L
Front Immunol; 2022; 13():917153. PubMed ID: 35711459
[TBL] [Abstract][Full Text] [Related]
13. Emerging Roles of N6-Methyladenosine Demethylases and Its Interaction with Environmental Toxicants in Digestive System Cancers.
Liu C; Yang S; Zhang Y; Wang C; Du D; Wang X; Liu T; Liang G
Cancer Manag Res; 2021; 13():7101-7114. PubMed ID: 34526822
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between N6-methyladenosine (m6A) modification and noncoding RNA in tumor microenvironment.
Wang D; Han Y; Peng L; Huang T; He X; Wang J; Ou C
Int J Biol Sci; 2023; 19(7):2198-2219. PubMed ID: 37151887
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive Analysis of PD-L1 Expression, Immune Infiltrates, and m6A RNA Methylation Regulators in Esophageal Squamous Cell Carcinoma.
Guo W; Tan F; Huai Q; Wang Z; Shao F; Zhang G; Yang Z; Li R; Xue Q; Gao S; He J
Front Immunol; 2021; 12():669750. PubMed ID: 34054840
[TBL] [Abstract][Full Text] [Related]
16. m6A Regulator-Mediated Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Acute Myeloid Leukemia.
Du A; Wu X; Gao Y; Jiang B; Wang J; Zhang P; Zhao Q
Front Immunol; 2021; 12():789914. PubMed ID: 34887874
[TBL] [Abstract][Full Text] [Related]
17. Insights into N6-methyladenosine (m6A) modification of noncoding RNA in tumor microenvironment.
Zhang Y; Zhan L; Li J; Jiang X; Yin L
Aging (Albany NY); 2023 May; 15(9):3857-3889. PubMed ID: 37178254
[TBL] [Abstract][Full Text] [Related]
18. N6-Methyladenosine RNA Modification in the Tumor Immune Microenvironment: Novel Implications for Immunotherapy.
Guo L; Yang H; Zhou C; Shi Y; Huang L; Zhang J
Front Immunol; 2021; 12():773570. PubMed ID: 34956201
[TBL] [Abstract][Full Text] [Related]
19. m6A regulator-mediated RNA methylation modification patterns are involved in immune microenvironment regulation of periodontitis.
Zhang X; Zhang S; Yan X; Shan Y; Liu L; Zhou J; Kuang Q; Li M; Long H; Lai W
J Cell Mol Med; 2021 Apr; 25(7):3634-3645. PubMed ID: 33724691
[TBL] [Abstract][Full Text] [Related]
20. METTL14‑mediated RNA methylation in digestive system tumors.
Hu J; Lin H; Wang C; Su Q; Cao B
Int J Mol Med; 2023 Sep; 52(3):. PubMed ID: 37539726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
